Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,066,000 shares of common stock (or pre-funded warrants in lieu the ...

Company Overview - Phytanix Bio is a preclinical stage pharmaceutical company focused on developing therapeutics based on cannabinoid and cannabinoid-like molecules [1][15] - The company was founded by former members of GW Pharmaceuticals, leveraging their extensive experience and intellectual property to create innovative therapies for serious unmet medical needs [15] Strategic Vision and Growth Potential - The newly released investor deck outlines Phytanix Bio's strategic vision, scientific advancements, and growth potential as it progresses towards next-generation cannabinoid medicines [1][10] - The global cannabis pharmaceuticals market was estimated at USD 3.4 billion in 2023 and is projected to grow at a CAGR of 53.3% from 2024 to 2030, indicating significant market opportunities for Phytanix Bio [13] Scientific and Clinical Progress - The investor deck provides detailed updates on the company's preclinical studies, research collaborations, and upcoming clinical milestones [14] - Phytanix Bio is developing lead product candidates aimed at treating treatment-resistant facial seizures and Painful Bladder Syndrome (PBS) [14] Intellectual Property Portfolio - The company holds exclusive intellectual property related to cannabinoid and cannabinoid-like medicines, including patents and proprietary technologies [14] Management Team - The leadership team includes experienced professionals such as CEO Barrett Evans, COO Colin Stott, and Chief Legal Officer Dominic Schiller, all of whom are former key members of GW Pharmaceuticals [14] Business Combination Agreement - Phytanix Bio has entered into a Business Combination Agreement with Chain Bridge I (Nasdaq: CBRG), a blank-check company, to facilitate a merger or similar business combination [3][10]

Core Insights - BLAQclouds, Inc. has engaged ZEUS Blockchain Partners to develop and manage the "BLAQ" token, which will operate on both Ethereum and ZEUS blockchains [1][4] - The BLAQ token will have a total supply of 500 million tokens, with a planned price of $0.01 per token and a pre-launch price of $0.005 [1][5] - The BLAQ token will integrate with the DiVinciPay merchant platform, allowing holders to use BLAQ tokens as currency at participating merchants [1] Token Details - The BLAQ token will utilize layered smart contracts for funding liquidity pools on the ZEUS Chain, automating funding and managing distributions via time-locked contracts [5] - The token will operate under the ERC20 and ZRC20 standards, with a contract address of 0x81324d217089CEe039e3b660d9265FfeBBF534cD [1] - There will be no reflections or taxes associated with the BLAQ token, and the Uniswap pool fee is set at 0.03% [1] Company Overview - BLAQclouds, Inc. is a publicly traded company based in Nevada, specializing in artificial intelligence and innovative blockchain technology solutions [6] - The company aims to deliver high-performance, secure, and scalable AI-powered blockchain solutions, focusing on future growth and value addition for shareholders [6] - The company has updated its communication strategy, urging shareholders to disregard past social media posts and to rely on verified channels for information [2]

Core Insights - AmpliTech Group, Inc. has launched new Cryogenic Power Supplies designed for the quantum computing industry, available in two models with adjustable low-voltage outputs [1][2] - The new products complement the existing line of cryogenic low noise amplifiers, showcasing the company's commitment to innovation in critical industries [2] - AmpliTech Group operates multiple divisions and serves various global markets, including telecommunications, satellite communications, and quantum computing [3] Product Details - The Cryogenic Power Supplies are ergonomic bench-top models ideal for reliability testing, laboratory instrument testing, and cryogenic amplifier testing [1] - The products are available for individual purchase or as a set with AmpliTech's cryogenic amplifiers [1] Company Overview - AmpliTech Group, Inc. consists of five divisions and is a leading designer, developer, manufacturer, and distributor of RF microwave components and 5G network solutions [3] - The company is focused on advancing technology and innovation across various sectors, including space exploration and defense [3]

Core Viewpoint - AmpliTech Group is committed to executing its business plan and delivering innovative products in the communications sector, particularly in 5G and quantum computing, while addressing recent challenges and maintaining strong financial discipline [2][3][4][6]. Company Developments - The company has not engaged in digital currency investments, and any past incidents related to fraudulent activity have been reported to authorities [3]. - AmpliTech has a history of no debt and avoidance of dilutive financing, reflecting its commitment to shareholder equity [3]. Product Innovations - AmpliTech has developed several new products for Public and Private 5G, LEO Satellite constellations, and quantum computing, positioning itself in rapidly growing industrial sectors with total addressable markets exceeding trillions of dollars [4]. - The company is the only US-based manufacturer of a full suite of private and commercial 5G radios, providing data speeds over 1 Gbps, which are essential for modern applications like the Metaverse and automated vehicles [4]. - AmpliTech also produces cryogenic Low Noise Amplifiers (LNAs) for quantum computers and LNBs with the lowest noise figures in the industry, crucial for satellite communications [4]. Strategic Vision - The company has evolved from a single product focus to a comprehensive communications systems provider, demonstrating dedication and progress since its uplisting to Nasdaq [5]. - AmpliTech maintains a robust pipeline of leads and continues to sell new products through its online store, generating daily revenue [6]. - The management team is focused on advancing technology development and maintaining a leadership position in key markets, including 5G and quantum computing [6].

Core Viewpoint - REMSleep Holdings, Inc. has received 510(K) clearance for its Deltawave CPAP Pillows Interface mask, allowing the company to prepare for market introduction [1][7]. Company Overview - REMSleep Holdings, Inc. is a medical device manufacturer focused on developing products for the treatment of obstructive sleep apnea and other respiratory conditions, with over 30 years of collective experience in CPAP therapy [4]. Product Development and Market Preparation - Following the 510(K) clearance, the company will update its website, order large inventory, engage with potential distributors, and manage marketing efforts, emphasizing the product's exceptional performance as a key marketing strategy [2]. Regulatory Information - The Deltawave CPAP interface is classified as a Class II device under the regulation number 21 CFR 868.5905, and it has been deemed substantially equivalent to legally marketed predicate devices [8]. Shareholder Communication - The company encourages shareholders to stay informed through press releases and social media channels [3]. Market Monitoring - REMSleep has identified imbalances and reported short interest, indicating potential illegal naked short sales, and is committed to monitoring these activities to protect shareholder interests [9].

BEND, OR, June 28, 2024 – BranchOut Food Inc. (NASDAQ: BOF), ("BranchOut" or the "Company"), a leading food technology company specializing in dehydrated fruit and vegetable-based products, today announced the closing of its underwritten public offering of 1,750,000 shares of common stock at a public offering price of $0.80 per share. The gross proceeds from the offering, before underwriting discounts and commissions and estimated offering expenses payable by the Company, are approximately $1,400,000. In ad ...

BranchOut Food Announces Nation's Largest Retailer Increases Third Contract to Approximately $1M Annually, Triples Original Commitment BEND, Ore., June 27, 2024 — BranchOut Food Inc. (NASDAQ: BOF), a pioneering food technology company and producer of dehydrated fruit and vegetable-based products, today announced that the nation's largest retailer has increased the store count and overall projected sales of its third contract with BranchOut Food. The new third contract now has a value of approximately $1 mil ...

Company Overview - BranchOut Food Inc. is a leading food technology company specializing in dehydrated fruit and vegetable-based products, protected by over 17 patents [11]. Offering Details - The company announced a public offering of 1,750,000 shares of common stock at a price of $0.80 per share, expecting gross proceeds of approximately $1,400,000 before underwriting discounts and commissions [3][4]. - The underwriters have a 45-day option to purchase up to 262,500 additional shares at the public offering price [3]. Use of Proceeds - The net proceeds from the offering will be used for working capital and general corporate purposes, including operating expenses and capital expenditures [4]. Closing Information - The offering is expected to close on or about June 28, 2024, subject to customary closing conditions [9].

BranchOut Food Ships First Production of New, Innovative Products to Nation's Largest Retailer, Initiating Second of Three Existing Contracts Totaling $8M BranchOut Food contracts with the retailer now total approximately $8 million in annualized revenue New dried vegetable offerings have shipped ahead of a nationwide launch in July 2024 BEND, Ore., June 26, 2024 — BranchOut Food Inc. (NASDAQ: BOF), a leading food technology company specializing in dehydrated fruit and vegetablebased products, today announc ...